Pembrolizumab is commonly employed in research and production environments as an immunoglobulin G4 monoclonal antibody. Its molecular formula is C85H170N4OS, with a molecular weight of 1296.4. This compound belongs to the class of proteins known as monoclonal antibodies, which are engineered immune system components designed to target specific antigens. Handling requires standard precautions for biological substances, including Pembrolizumab exhibits high affinity for programmed death-1 (PD-1) proteins, inhibiting their interaction with programmed death ligand-1 (PD-L1) and programmed death ligand-2 (PD-L2), thereby enhancing T cell activity against cancer cells.

• CAS Number: 1374853-91-4
• Exact Mass: 1295.30953723
• Molecular Formula: C85H170N4OS
• Molecular Weight: 1296.4